OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
1.680
+0.050 (3.07%)
At close: Oct 6, 2025, 4:00 PM EDT
1.710
+0.030 (1.77%)
After-hours: Oct 6, 2025, 7:09 PM EDT
OmniAb Revenue
OmniAb had revenue of $3.90M in the quarter ending June 30, 2025, a decrease of -48.82%. This brings the company's revenue in the last twelve months to $23.03M, up 6.05% year-over-year. In the year 2024, OmniAb had annual revenue of $26.39M, down -22.75%.
Revenue (ttm)
$23.03M
Revenue Growth
+6.05%
P/S Ratio
7.42
Revenue / Employee
$201,991
Employees
114
Market Cap
241.85M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.39M | -7.77M | -22.75% |
| Dec 31, 2023 | 34.16M | -24.91M | -42.17% |
| Dec 31, 2022 | 59.08M | 24.33M | 70.02% |
| Dec 31, 2021 | 34.75M | 11.48M | 49.34% |
| Dec 31, 2020 | 23.27M | 4.95M | 27.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
OABI News
- 4 weeks ago - OmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment Conference - Business Wire
- 5 weeks ago - Top 3 Health Care Stocks You'll Regret Missing This Quarter - Benzinga
- 6 weeks ago - OmniAb Announces $30 Million Private Placement - Business Wire
- 2 months ago - OmniAb, Inc. (OABI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights - Business Wire
- 2 months ago - OmniAb to Report Second Quarter 2025 Financial Results on August 6 - Business Wire
- 5 months ago - OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit - Business Wire
- 5 months ago - OmniAb, Inc. (OABI) Q1 2025 Earnings Call Transcript - Seeking Alpha